ACTA worries raised at the WTO

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

ACTA worries raised at the WTO

Brussels was the setting for impassioned debate over the EU's approach to ACTA this week. But it wasn’t the only place where concerns were raised in Europe

The issue was on the agenda of Tuesday’s meeting of the WTO’s TRIPs Council meeting in Geneva – which in itself caused a row between the ACTA signatories on the Council and those not party to the negotiations.

Managing IP understands that India, Venezuela, Egypt and Ecuador questioned why the issue had been tabled for discussion as an agenda item, rather than as any other business. Once a decision had been taken to keep it on the agenda, representatives from those countries that have signed the anti-counterfeiting deal defended it, saying that it would not limit freedom of expression or target generic medicines.

But India claimed that ACTA would undermine the flexibilities in the TRIPs Agreement that make it easier for developing countries to produce and export generic pharmaceuticals and referred to cases in the EU where Indian-made medicines have been seized by Customs officers in the EU.

India was not the only country to raise ACTA-related worries. Bangladesh shared its concerns about access to medicines, while China noted that many of its provisions are TRIPs-plus. The Brazilian representative repeated concerns that that the country had made before about efforts to harmonise IP rules: that one-size does not fit all.



more from across site and SHARED ros bottom lb

More from across our site

A $110 million US verdict against Apple and an appellate order staying a $39 million trademark infringement finding against Amazon were also among the top talking points
Attorneys are watching how AI affects trademark registrations and whether a SCOTUS ruling from last year will have broader free speech implications
Patent lawyers explain why they will be keeping an eye on the implications of a pharma case and on changes at the USPTO in the second half of 2025
The insensitive reaction to a UK politician crying on TV proves we have a long way to go before we can say we are tackling workplace wellbeing
Adrian Percer says he was impressed by the firm’s work on billion-dollar cases as well as its culture
In our latest interview with women IP leaders, Catherine Bonner at Murgitroyd discusses technology, training, and teaching
Developments included an update in the VAR dispute between Ballinno and UEFA, the latest CMS updates, and a swathe of market moves
The LMG Life Sciences Americas Awards is thrilled to present the 2025 shortlist
A new order has brought the total security awarded to a Canadian tech company to $45 million, the highest-ever by an Indian court in an IP case
Andrew Blattman reflects on how IP practices have changed and shares his hopes for increased AI use and better performance on the stock market
Gift this article